184 related articles for article (PubMed ID: 32261653)
1. Improving the oral delivery efficiency of anticancer drugs by chitosan coated polycaprolactone-grafted hyaluronic acid nanoparticles.
Huang P; Yang C; Liu J; Wang W; Guo S; Li J; Sun Y; Dong H; Deng L; Zhang J; Liu J; Dong A
J Mater Chem B; 2014 Jul; 2(25):4021-4033. PubMed ID: 32261653
[TBL] [Abstract][Full Text] [Related]
2. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
Deng L; Dong H; Dong A; Zhang J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
[TBL] [Abstract][Full Text] [Related]
3. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
4. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
[TBL] [Abstract][Full Text] [Related]
5. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
[TBL] [Abstract][Full Text] [Related]
6. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-based polyelectrolyte complexes as potential nanoparticulate carriers: physicochemical and biological characterization.
Ramasamy T; Tran TH; Cho HJ; Kim JH; Kim YI; Jeon JY; Choi HG; Yong CS; Kim JO
Pharm Res; 2014 May; 31(5):1302-14. PubMed ID: 24297070
[TBL] [Abstract][Full Text] [Related]
8. [Polyelectrolyte layer-by-layer assembled lipid nanoparticles for improving oral absorption of doxorubicin].
Shen AJ; Xia DN; Gan Y; Li J
Yao Xue Xue Bao; 2016 Jul; 51(7):1136-43. PubMed ID: 29897223
[TBL] [Abstract][Full Text] [Related]
9. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
[TBL] [Abstract][Full Text] [Related]
11. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
12. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
Shahab MS; Rizwanullah M; Alshehri S; Imam SS
Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
[TBL] [Abstract][Full Text] [Related]
14. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
Gao Z; Li Z; Yan J; Wang P
Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-Loaded TPGS
Zou L; Zhang Z; Feng J; Ding W; Li Y; Liang D; Xie T; Li F; Li Y; Chen J; Yang X; Tang L; Ding W
J Pharm Sci; 2022 Jun; 111(6):1776-1784. PubMed ID: 35341722
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of chitosan-grafted-polycaprolactone micelles for modulate intestinal paclitaxel delivery.
Almeida A; Silva D; Gonçalves V; Sarmento B
Drug Deliv Transl Res; 2018 Apr; 8(2):387-397. PubMed ID: 28116655
[TBL] [Abstract][Full Text] [Related]
17. Catechol-modified chitosan/hyaluronic acid nanoparticles as a new avenue for local delivery of doxorubicin to oral cancer cells.
Pornpitchanarong C; Rojanarata T; Opanasopit P; Ngawhirunpat T; Patrojanasophon P
Colloids Surf B Biointerfaces; 2020 Dec; 196():111279. PubMed ID: 32750605
[TBL] [Abstract][Full Text] [Related]
18. Development and Evaluation of a Novel Hyaluronic Acid and Chitosan-modified Phytosome for Co-delivery of Oxymatrine and Glycyrrhizin for Combination Therapy.
Chen X; Yu S; Wang P; Zhao X; Sang G
Recent Pat Anticancer Drug Discov; 2024; 19(2):154-164. PubMed ID: 38214355
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecin.
Duan K; Zhang X; Tang X; Yu J; Liu S; Wang D; Li Y; Huang J
Colloids Surf B Biointerfaces; 2010 Apr; 76(2):475-82. PubMed ID: 20047821
[TBL] [Abstract][Full Text] [Related]
20. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery.
Liu Y; Zhou C; Wang W; Yang J; Wang H; Hong W; Huang Y
Mol Pharm; 2016 Dec; 13(12):4209-4221. PubMed ID: 27796093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
